CD163 and synovial sarcoma: The most common phenotype is M2, and low CD163+ levels are associated with favorable survival in synovial sarcoma [15]; in embryonic rhabdomyosarcoma, on the other hand, high levels of CD163+ are positively associated with survival [22].